Elevated expression of the miR-17-92 polycistron and miR-21 in hepadnavirus-associated hepatocellular carcinoma contributes to the malignant phenotype - Wikidata - awgldk - TriplyDB

Elevated expression of the miR-17-92 polycistron and miR-21 in hepadnavirus-associated hepatocellular carcinoma contributes to the malignant phenotype

Elevated expression of the miR-17-92 polycistron and miR-21 in hepadnavirus-associated hepatocellular carcinoma contributes to the malignant phenotype

http://www.wikidata.org/entity/Q24656088

about

Down-regulation of miR-92 in human plasma is a novel marker for acute leukemia patients Foxo3a regulates apoptosis by negatively targeting miR-21 MicroRNAs as possible biomarkers for diagnosis and prognosis of hepatitis B- and C-related-hepatocellular-carcinoma MicroRNAs Expressed during Viral Infection: Biomarker Potential and Therapeutic Considerations MicroRNAs as Important Players in Host-hepatitis B Virus Interactions Hepatitis B Virus Infection, MicroRNAs and Liver Disease Post-transcriptional regulation of MTA family by microRNAs in the context of cancer The role of microRNAs in human liver cancers The miR-17/92 cluster: a comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and disease Role of epigenetic aberrations in the development and progression of human hepatocellular carcinoma Involvement of inflammation and its related microRNAs in hepatocellular carcinoma Insights for hepatitis C virus related hepatocellular carcinoma genetic biomarkers: Early diagnosis and therapeutic intervention STAT3 upregulates miR-92a to inhibit RECK expression and to promote invasiveness of lung cancer cells miR-17-5p Promotes migration of human hepatocellular carcinoma cells through the p38 mitogen-activated protein kinase-heat shock protein 27 pathway Environmental chemical exposures and human epigenetics Design of a small molecule against an oncogenic noncoding RNA Discovery of chicken microRNAs associated with lipogenesis and cell proliferation.MiRNA-99a directly regulates AGO2 through translational repression in hepatocellular carcinoma TGFβR2 is a major target of miR-93 in nasopharyngeal carcinoma aggressiveness.microRNA 21: response to hormonal therapies and regulatory function in leiomyoma, transformed leiomyoma and leiomyosarcoma cells.miR-106b-25/miR-17-92 clusters: polycistrons with oncogenic roles in hepatocellular carcinoma Anticancer Role of PPARgamma Agonists in Hematological Malignancies Found in the Vasculature, Marrow, and Eyes.Impact on cell to plasma ratio of miR-92a in patients with acute leukemia: in vivo assessment of cell to plasma ratio of miR-92a.Phenethyl isothiocyanate (PEITC) suppresses prostate cancer cell invasion epigenetically through regulating microRNA-194.microRNA and cancer Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies Therapeutics Based on microRNA: A New Approach for Liver Cancer MicroRNA-224 is up-regulated in hepatocellular carcinoma through epigenetic mechanisms.Analysis of serum micro-RNAs as potential biomarker in chronic obstructive pulmonary disease.MicroRNAs associated with HBV infection and HBV-related HCC.Complex interactions between microRNAs and hepatitis B/C viruses.Role of MicroRNAs in Hepatocellular Carcinoma Over-expression of miR-106b promotes cell migration and metastasis in hepatocellular carcinoma by activating epithelial-mesenchymal transition process The miR-221/222 cluster, miR-10b and miR-92a are highly upregulated in metastatic minimally invasive follicular thyroid carcinoma.MicroRNAs in liver cancer: a model for investigating pathogenesis and novel therapeutic approaches.The role of JNK in the development of hepatocellular carcinoma.microRNA-92a promotes lymph node metastasis of human esophageal squamous cell carcinoma via E-cadherin.MicroRNA as a Novel Modulator in Head and Neck Squamous Carcinoma Microarray and deep sequencing cross-platform analysis of the mirRNome and isomiR variation in response to epidermal growth factor.Inferring potential microRNA-microRNA associations based on targeting propensity and connectivity in the context of protein interaction network

P2860

Q21143782-70D9CA40-FCAD-4917-87BC-D30F060E6DBC Q24305974-289527A7-D9C8-41B8-BD6D-495EC9055F25 Q26751392-3FBC2D44-8C82-42E1-9116-901391CBE2E5 Q26773183-BF498B16-0473-469D-A91D-3CED290D47E4 Q26781737-B2F7BEF5-2591-46A4-B0D0-2A9DC20FD9C2 Q26801511-70668715-6CC9-44BB-A879-BE942F8A86D6 Q26827361-7AD6EDE1-653D-4458-9B14-5CA05237DD5A Q26861699-6A8D669A-72E4-4A74-A21B-421D10335D1F Q27015587-A7D6D4CA-3FAE-4D71-8CD3-B7949B55DFEF Q27023524-244CE1A8-EFB9-4DF3-AC13-B1FECB3EE45E Q28079138-59345C59-2202-47C0-BF89-8D4CA4AE8049 Q28080281-E96A561A-4CA5-4D34-BF02-C6005DDC0FF4 Q28118347-42109159-403B-4787-AA85-38CE108767CE Q28275238-AFFD29B0-BA32-4DE9-9809-099B7BD36623 Q28397621-D759591D-A452-48C5-B53C-449CC53D4C44 Q28829505-7EE105C1-EB68-416A-B4E7-6A8CFC7E1E14 Q30977229-5052B432-697A-4DB9-9579-E3576E5F7847 Q33555052-67C9A27E-13B3-4CD6-9598-73FDD1577598 Q33592822-90DBFF0F-8566-474B-82CA-EB41F0D355D5 Q33629095-D96CEF56-D3B3-47E4-B679-1EF14534E811 Q33661028-6450C8C6-FC2D-4740-81FE-D1F9300ACC94 Q33692555-752F7D6A-C5D2-459A-9176-BAB9DAFA5297 Q33779632-4E07C640-E662-4C23-BEA4-5F41AD3E27A1 Q33865456-1337EE71-511F-4A15-AE7E-B38E470945BE Q33954625-C2E2E837-5301-4A8B-A890-84C548142116 Q34135877-ABD7B855-DB13-4DC7-AFA8-59177974DCD3 Q34152847-975997BE-101C-485F-BF6A-F8F3DC9FE951 Q34264405-487080D4-6920-4997-B75B-558DD71764F3 Q34280453-E037D86A-437E-44A9-BF32-C03B736F859C Q34284404-CD7472FA-3430-4F71-89AA-0187F2C53880 Q34302987-B48E76AD-51EF-49E3-9095-538427905576 Q34348824-7C49153A-AD84-4111-BB13-3C758C5A7111 Q34618415-C92A0A54-C105-49F4-B80F-0C121B01DB7F Q34657471-EF6A36DD-6D56-4A7B-9FDB-138D800AC5E6 Q34675280-C64D1799-3C6A-4A4D-B340-1FF678D90CF6 Q34691340-AD09F504-5A98-4BE0-942E-6CBCDDF8F0BF Q34695995-3D3E127C-4D81-4A74-97E9-37E764AFA98C Q34725426-FC13C4A2-621D-4E31-89F1-4DB0B44BB8C3 Q34750470-8C5F887F-5E91-4593-9CFA-7ECF13F59545 Q34854544-C8E714E5-D090-467D-AE2A-79088B129F47

P2860

Elevated expression of the miR-17-92 polycistron and miR-21 in hepadnavirus-associated hepatocellular carcinoma contributes to the malignant phenotype

http://www.wikidata.org/entity/Q24656088

description

2008 nî lūn-bûn

@nan

2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Elevated expression of the miR ...... tes to the malignant phenotype

@ast

Elevated expression of the miR ...... tes to the malignant phenotype

@en

Elevated expression of the miR ...... tes to the malignant phenotype

@nl

type

label

Elevated expression of the miR ...... tes to the malignant phenotype

@ast

Elevated expression of the miR ...... tes to the malignant phenotype

@en

Elevated expression of the miR ...... tes to the malignant phenotype

@nl

prefLabel

Elevated expression of the miR ...... tes to the malignant phenotype

@ast

Elevated expression of the miR ...... tes to the malignant phenotype

@en

Elevated expression of the miR ...... tes to the malignant phenotype

@nl

P1433

Q24656088-E40445F8-C750-4256-8845-499821D26B49

P1476

Q24656088-613EAEAF-6DA9-40FB-872A-9BE9EFE54C74

P2093

Q24656088-0156DA85-0E55-4FCC-89C6-69C270CF9DCB

Q24656088-08243DF8-C955-4995-B891-6C8275E42CB3

Q24656088-1DE37AD2-7840-4822-B6E1-B9294E61225D

Q24656088-3F8C5F03-2C71-4ED9-9E63-6F9B3305454B

Q24656088-42FC0F69-22E0-45DF-A9DE-944D5B816335

Q24656088-A264FAFD-1135-4153-94DA-FE204414F688

Q24656088-A66D64DA-DBE2-44D7-A743-AD6B52648D8C

Q24656088-B462ED08-0FC1-41C0-BABC-E1FCBE582C23

P2860

Q24656088-0FE12E14-19BD-44DA-B347-2C25F51A23BA

Q24656088-0FE21739-1B2C-4EE9-B92D-BFDF2AE96CBD

Q24656088-15D06A0E-228D-4C80-A97D-BBF2F7482229

Q24656088-19B61579-ADEC-43B8-9470-08F8CAAAF0DC

Q24656088-1FA6482F-8A97-4DE1-8564-48A2D7C3D3A7

Q24656088-2843CC08-C43D-4B3B-AE1E-8F781ACBEBB7

Q24656088-3BF57802-EA56-4AA2-B006-6B2F88316231

Q24656088-3DE21F15-78F5-4A71-9669-96FEE3222997

Q24656088-4322319F-270D-4E05-9BBC-CD48F23D5FB5

Q24656088-46955271-BB26-4BB0-912F-52CF93046B24

P304

Q24656088-7BD97790-6B67-4AF9-BD01-C87BCB1097C0

P31

Q24656088-8775A53C-C0B0-4753-BAC4-31C7374EA6E1

P3181

Q24656088-0268E193-7212-465E-87F8-11BCD738C9A5

P356

Q24656088-A566F46F-1823-4429-AF9A-DD7ED1BFEFFA

P407

Q24656088-3829347E-F76C-4BC7-AB29-C470ADDA5CC0

P433

Q24656088-266E12E1-3E18-4CC9-9B8F-5C706B73D6CC

P478

Q24656088-D95890F6-2E13-42F7-8D0B-ED5BA8D97A6F

P50

Q24656088-19387956-96B3-4C10-AC41-38471A88EE5B

Q24656088-A697C901-157A-448F-ABA4-F05153266EA0

P577

Q24656088-687933E4-943A-408C-BC8C-051531A0709E

P5875

Q24656088-BB19E860-D1FC-40A3-BF7E-4424DAAC22E0

P698

Q24656088-74ECF3FD-903E-4C3F-B89D-7C0F9F322EE7

P921

Q24656088-5DF3A0B7-56C6-4457-A514-03D068264698

P932

Q24656088-B1B16474-FFE6-4A9C-B234-96C2537474A2

P3181

P356

AJPATH.2008.080096

P1433

The American Journal of Pathology

P1476

Elevated expression of the miR ...... tes to the malignant phenotype

@en

P2093

Betty L Slagle

http://www.w3.org/2001/XMLSchema#string

Bud C Tennant

http://www.w3.org/2001/XMLSchema#string

Charles E Rogler

http://www.w3.org/2001/XMLSchema#string

Erin Connolly

http://www.w3.org/2001/XMLSchema#string

Leslie E Rogler

http://www.w3.org/2001/XMLSchema#string

Margherita Melegari

http://www.w3.org/2001/XMLSchema#string

Pablo Landgraf

http://www.w3.org/2001/XMLSchema#string

Tatyana Tchaikovskaya

http://www.w3.org/2001/XMLSchema#string

P2860

MicroRNA targeting specificity in mammals: determinants beyond seed pairing

Downregulation of miR-122 in the rodent and human hepatocellular carcinomas

A mammalian microRNA expression atlas based on small RNA library sequencing

A microRNA polycistron as a potential human oncogene

Oncomirs - microRNAs with a role in cancer

RT-PCR-based analysis of microRNA (miR-1 and -124) expression in mouse CNS

A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation

Translational repression of E2F1 mRNA in carcinoma in situ and normal testis correlates with expression of the miR-17-92 cluster

Hepatocellular carcinoma in cirrhosis: incidence and risk factors

Concomitant MYC and microRNA cluster miR-17-92 (C13orf25) amplification in human mantle cell lymphoma

P304

856-64

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1829273

http://www.w3.org/2001/XMLSchema#string

P356

10.2353/AJPATH.2008.080096

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

173

http://www.w3.org/2001/XMLSchema#string

P50

Mihaela Zavolan

P577

2008-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23156824

http://www.w3.org/2001/XMLSchema#string

P698

18688024

http://www.w3.org/2001/XMLSchema#string

P921

P932

2527078

http://www.w3.org/2001/XMLSchema#string